Market Analysis — MCLAREN GREATER LANSING
MI market | 3 hospitals | HHI: 5,694 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
640
Total Beds
$1.3B
Market Revenue
Concentrated
HHI: 5,694
None
Moat Rating (3/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costsmoderate
Market Share28.6%
Top 3 Concentration100.0%
Network Density0.47
Margin vs Market-0.0%
Bed Util vs Market+4.9%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The MI market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 5,694).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full MI market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| EDWARD W. SPARROW HOSPITAL | 425 | $936M | 69.8% | 66.4% |
| SPARROW SPECIALTY HOSPITAL | 30 | $21M | 1.6% | 4.7% |
Regional Payer Mix
■ Medicare 27%■ Medicaid 5%■ Commercial 68%